Pricing checked against SAHPRA-registered providers Updated weekly
South Africa
Compare prices
Registered with SAHPRA

Saxenda prices in South Africa

Saxenda contains liraglutide, an earlier-generation GLP-1 receptor agonist from Novo Nordisk. Unlike Ozempic, Wegovy and Mounjaro, it's injected once daily rather than weekly, and is registered specifically for weight management. Below, current listed prices by dose across the providers we track.

Price comparison

Saxenda, by dose and provider

Sample data for site review. Figures are illustrative and will be replaced with verified provider pricing before launch. Pricing below is per pack, not per single daily dose.

DoseProviderTypePriceStock
0.6 mg starter dose, dailyProvider DTelehealthR3 100In stock
1.2 mg dailyProvider DTelehealthR3 100In stock
1.8 mg dailyProvider APharmacyR3 350In stock
2.4 mg dailyProvider APharmacyR3 350Limited
3.0 mg maintenance dose, dailyProvider DTelehealthR4 200In stock

Prices reflect provider list prices in ZAR per pack and exclude consultation fees. Note that Saxenda pens are typically supplied in fixed-dose packs regardless of titration step — confirm what a listed price actually includes with the provider. See our verification methodology.

What is Saxenda?

Saxenda is the brand name for liraglutide, a GLP-1 receptor agonist that predates semaglutide-based medications like Ozempic and Wegovy. It works through a similar appetite-regulating mechanism but requires a daily injection rather than a weekly one, and is generally dosed at a lower relative strength.

In South Africa, Saxenda is registered specifically for weight management, alongside diet and physical activity changes, rather than for diabetes control.

Daily, not weekly

The daily injection schedule is the biggest practical difference between Saxenda and the newer weekly options on this site. Some people prefer it; others prefer fewer injections per week. This is worth discussing with a prescriber.

Related medications

You may also want to compare Ozempic, Wegovy (both weekly semaglutide), or Mounjaro (a dual-mechanism weekly alternative).